The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so so these are a class of drugs that were initially developed for the management of type 2 diabetes and that was largely on the basis of the fact that these are a class of drugs that mimic a hormone called glp1 glucagon like peptide 1 that stimulates the release of insulin from the pancreas which of course if you have type two diabetes as opposed to type 1 diabetes is one of the routes of trying to get around the disease right
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
these are a class of drugs that mimic a hormone called glp1 glucagon like peptide 1 that stimulates the release of insulin from the pancreas
so so these are a class of drugs that were initially developed for the management of type 2 diabetes and that was largely on the basis of the fact that these are a class of drugs that mimic a hormone called glp1 glucagon like peptide 1 that stimulates the release of insulin from the pancreas